提醒成功
搜索
Monoclonal Antibody to Human ErbB2/Her2 (Trastuzumab, RUO)
Description |
|---|
Trastuzumab is a research-grade recombinant antibody targeting CD340. Produced in mammalian cells with native-like glycosylation. ●Highlights: ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns. ●Targets: CD340, EC:2.7.10.1, ERBB2, HER2, MLN 19, MLN19, Metastatic lymph node gene 19 protein, NEU, NGL, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Receptor tyrosine-protein kinase erbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2. ●Endotoxin level:< 10 EU/mg |
Specification |
|
|---|---|
| Aliases | timigutuzumab, 4D5-8, 4D5V8, Herceptin, rhuMabHER2, 180288-69-1 |
| Swissprot | P04626 |
| Host/Isotype | IgG1-kappa |
| Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Species Reactivity | Human |
| Formulation | 0.01M PBS pH 7.4. |
Application |
|
|---|---|
| ELISA | 1:1000-1:20000 |
Product Image
For Reseach Only
Application Key:WB - Western Blot | IHC - Immunohistochemistry | ICC - Immunocytochemistry | FCM - Flow Cytometry | ELISA - Enzyme-linked Immunosorbent Assay | IP - Immunoprecipitation
#51050
相关产品

微信/QQ登录


首页
